Thomas Jefferson UniversityJefferson Medical College

Main menu:

Kimmel Cancer Center Clinical Trials

03F.314 :   Bladder Cancer Treatment

Purpose: To determine whether giving chemotherapy and radiation therapy together will prevent having the bladder removed

Title:  RTOG #0233- A Phase II Randomized Trial for Patients with Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery and BID Irradiation Plus Either Paclitaxel and Cisplatin or 5 Fluorouracil and Cisplatin Followed by Selective Bladder Preservation and Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy.

Visit the Kimmel Cancer Center website for more information.


06F.145 :     Prostate Cancer Detection

Purpose:   To improve the detection of prostate cancer with targeted biopsy based upon contrast-enhanced ultrasound combined with short-term dutasteride therapy

Title: US Prostate Cancer Detection with Dutasteride Pretreatment  

Visit the Kimmel Cancer Center website for more information.  


02C.172 :    Prostate Cancer Progression Prevention

Purpose:  To determine how safe and effective Samarium-153, a radioactive drug, will be together with hormonal and radiation therapy to help prevent your cancer from spreading

Title:  A Phase I Pilot Study of Samarium-153 Combined with Neoadjuvant Hormonal Therapy and Radiation Therapy in Men with Locally Advanced Prostate Cancer

Visit the Kimmel Cancer Center website for more information. 


02F.229 :    Prostate Cancer Treatment

Purpose : T1b-T2b  Prostate Cancer

Title:  RTOG #P-0126- A Phase III Randomized Study of High Dose 3D-CRT in Patients Treated for Localized Prostate Cancer

Visit the Kimmel Cancer Center website for more information. 


03C.286 :    Prostate Cancer Treatment

Purpose:  To determine which is better treatment: a prostate implant alone or with external beam radiation therapy

Title:  RTOG#-0232 A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma.

Visit the Kimmel Cancer Center website for more information. 


06F.200 :   Prostate Cancer Treatment

Purpose:  To determine if a higher daily dose of radiation therapy is better than the standard dose

Title:  A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate Cancer [RTOG-0415].

Visit the Kimmel Cancer Center website for more information. 


06F.49 :   Prostate Cancer Treatment

Purpose:  To determine if adding chemotherapy to the standard treatment, hormones and radiation therapy, will better control localized high-risk prostate cancer

Title:  A Phase III Protocol of Androgen Suppresion (AS) and 3DCRT/IMRT vs. AS and 3DCRT/IMRT Followed by Chemotherapy with Docetaxel and Prednisone for Localized, High-Risk Prostate Cancer.

Visit the Kimmel Cancer Center website for more information. 


06F.302 :   Renal Cancer Treatment

Purpose:  A research study to compare the good and bad side effects and effectiveness of the investigational agents, Sunitinib and Sorafenib, in patients with renal cancer.

Title:  (CIRB) A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib Verses Placebo in Patients with Resected Renal Cell Carcinoma [E2805].

Visit the Kimmel Cancer Center website for more information.